OPK — OPKO Health, Inc.

OPKO Health, Inc. , a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Market Cap

$867.5M

P/E Ratio

-3.83

Beta

1.52

52-Week Range

1.1-1.64

Dividend Yield

$0.00

CEO

Phillip Frost

Employees

2,997

IPO Date

Nov 2, 1995

Exchange

NASDAQ